Related Experiment Videos
Brain arteriovenous malformations in adults.
1Stroke Centre, Neurological Institute, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. jchoi@neuro.columbia.edu <jchoi@neuro.columbia.edu>
The Lancet. Neurology
|April 26, 2005
Summary
Brain arteriovenous malformations (AVMs) pose a stroke risk. Research highlights the need for better understanding of treatment risks and benefits, especially for unruptured AVMs.
Area of Science:
- Neurology
- Neurosurgery
- Radiology
Background:
- Arteriovenous malformations of the brain (AMB) are vascular anomalies that can lead to cerebrovascular events like stroke.
- Approximately 50% of patients with AMB present with hemorrhage, while the remainder experience non-focal symptoms (headache, seizure) or are asymptomatic, with incidental findings.
- The management of AMB is a complex, interdisciplinary challenge focused on preventing hemorrhage.
Purpose of the Study:
- To review the current understanding of arteriovenous malformations of the brain.
- To highlight the challenges in treating AMB and the need for evidence-based approaches.
- To emphasize the limited research on risk-benefit ratios for treating unruptured AMB.
Main Methods:
- Review of epidemiological and imaging research on arteriovenous malformations of the brain.
- Analysis of presentation patterns, including hemorrhage and non-focal symptoms.
- Assessment of the current treatment landscape and research gaps.
Main Results:
- AMB present with hemorrhage in about 50% of cases.
- The other 50% of AMB patients present with non-focal symptoms or are asymptomatic.
- Significant resources are dedicated to AMB treatment, yet robust data on unruptured lesions is scarce.
Conclusions:
- Arteriovenous malformations of the brain represent a significant cause of stroke.
- Further research is critically needed to establish risk-benefit profiles for interventions on unruptured AMB.
- Developing optimal, evidence-based treatment strategies for all AMB presentations remains a key challenge.